Jeffrey Wiezorek Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey Wiezorek.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey Wiezorek. Jeffrey Wiezorek is SVP Clinical Development in Kite Pharma, Inc. ($KITE) and VP Clinical Development in Kite Pharma, Inc. ($KITE).

Latest Insider Trading Transactions of Jeffrey Wiezorek

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	46.09	38,500	1,774,465	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	63.87	14,850	948,470	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	63.87	11,550	737,699	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	51.96	5,031	261,411	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	51.96	11,069	575,145	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	6.89	29,167	200,961	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	D	6.89	28,833	198,659	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	D	0.00	11,150	0	0	11.2 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	U	180.00	14,674	2,641,320	11,150	25.8 K to 11.2 K (-56.82 %)
Sep 27 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	179.66	5,283	949,164	25,824	31.1 K to 25.8 K (-16.98 %)
Sep 27 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Grant	A	0.00	10,000	0	31,107	21.1 K to 31.1 K (+47.38 %)
Jul 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	10,000	68,900	58,000
Jul 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	104.76	1,201	125,817	21,071	22.3 K to 21.1 K (-5.39 %)
Jul 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	104.26	8,799	917,384	22,272	31.1 K to 22.3 K (-28.32 %)
Jul 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	10,000	68,900	31,071	21.1 K to 31.1 K (+47.46 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	18,000	124,020	68,000
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	79.83	160	12,773	21,071	21.2 K to 21.1 K (-0.75 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	78.97	311	24,560	21,231	21.5 K to 21.2 K (-1.44 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	76.98	150	11,547	21,542	21.7 K to 21.5 K (-0.69 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	75.82	157	11,904	21,692	21.8 K to 21.7 K (-0.72 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	75.00	16,561	1,242,075	21,849	38.4 K to 21.8 K (-43.12 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	72.36	328	23,734	38,410	38.7 K to 38.4 K (-0.85 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	71.24	259	18,451	38,738	39 K to 38.7 K (-0.66 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	68.92	74	5,100	38,997	39.1 K to 39 K (-0.19 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	18,000	124,020	39,071	21.1 K to 39.1 K (+85.43 %)
Feb 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	86,000
Feb 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.21	1,500	76,820	20,695	22.2 K to 20.7 K (-6.76 %)
Feb 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	22,195	20.7 K to 22.2 K (+7.25 %)
Jan 10 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	87,500
Jan 10 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.00	1,500	75,000	20,695	22.2 K to 20.7 K (-6.76 %)
Jan 10 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	22,195	20.7 K to 22.2 K (+7.25 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Grant	A	0.00	5,600	0	20,695	15.1 K to 20.7 K (+37.10 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.86	716	36,416	15,095	15.8 K to 15.1 K (-4.53 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	89,000
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.23	207	10,605	15,811	16 K to 15.8 K (-1.29 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.68	1,293	65,529	16,018	17.3 K to 16 K (-7.47 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	76,208
Nov 14 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.18	1,500	75,270	15,811	17.3 K to 15.8 K (-8.67 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	77,708
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	55.51	170	9,437	15,811	16 K to 15.8 K (-1.06 %)
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	54.72	1,330	72,778	15,981	17.3 K to 16 K (-7.68 %)
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	79,208
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	58.58	262	15,348	15,811	16.1 K to 15.8 K (-1.63 %)
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	58.17	1,238	72,014	16,073	17.3 K to 16.1 K (-7.15 %)
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	80,708
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	57.24	609	34,859	14,867	15.5 K to 14.9 K (-3.94 %)
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	56.66	891	50,484	15,476	16.4 K to 15.5 K (-5.44 %)
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	16,367	14.9 K to 16.4 K (+10.09 %)
Jul 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	82,208
Jul 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.00	1,500	75,007	14,867	16.4 K to 14.9 K (-9.16 %)
Jul 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	16,367	14.9 K to 16.4 K (+10.09 %)
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	83,708
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	85,208
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.90	175	9,083	14,867	15 K to 14.9 K (-1.16 %)
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.22	1,325	67,867	15,042	16.4 K to 15 K (-8.10 %)
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	16,367	14.9 K to 16.4 K (+10.09 %)
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.00	1,500	75,000	14,867	16.4 K to 14.9 K (-9.16 %)
Jun 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	16,367	14.9 K to 16.4 K (+10.09 %)
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	7,292	50,242	86,708
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,708	11,768	14,292
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	47.82	259	12,385	14,867	15.1 K to 14.9 K (-1.71 %)
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	46.49	461	21,432	15,126	15.6 K to 15.1 K (-2.96 %)
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	45.32	1,538	69,702	15,587	17.1 K to 15.6 K (-8.98 %)
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	44.56	6,742	300,424	17,125	23.9 K to 17.1 K (-28.25 %)
Mar 17 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	23,867	14.9 K to 23.9 K (+60.54 %)
Feb 18 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	9,000	62,010	16,000
Feb 18 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	A	6.89	25,000	172,250	25,000
Feb 18 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	44.47	1,388	61,724	13,742	15.1 K to 13.7 K (-9.17 %)
Feb 18 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	44.00	7,612	334,928	15,130	22.7 K to 15.1 K (-33.47 %)
Feb 18 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	22,742	13.7 K to 22.7 K (+65.49 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	9,000	62,010	94,000
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	57.75	200	11,550	13,742	13.9 K to 13.7 K (-1.43 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	57.11	648	37,007	13,942	14.6 K to 13.9 K (-4.44 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	55.98	1,121	62,754	14,590	15.7 K to 14.6 K (-7.14 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	55.17	5,987	330,303	15,711	21.7 K to 15.7 K (-27.59 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	53.87	670	36,093	21,698	22.4 K to 21.7 K (-3.00 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	52.60	374	19,672	22,368	22.7 K to 22.4 K (-1.64 %)
Jan 19 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	22,742	13.7 K to 22.7 K (+65.49 %)
Dec 21 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	A	63.87	26,400	1,686,168	26,400
Dec 21 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Grant	A	0.00	7,400	0	13,742	6.3 K to 13.7 K (+116.68 %)
Dec 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	9,000	62,010	103,000
Dec 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	65.27	491	32,048	6,342	6.8 K to 6.3 K (-7.19 %)
Dec 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	64.58	3,488	225,255	6,833	10.3 K to 6.8 K (-33.80 %)
Dec 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	63.59	2,285	145,303	10,321	12.6 K to 10.3 K (-18.13 %)
Dec 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	62.64	2,736	171,383	12,606	15.3 K to 12.6 K (-17.83 %)
Dec 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	15,342	6.3 K to 15.3 K (+141.91 %)
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	9,000	62,010	112,000
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	80.20	90	7,218	6,342	6.4 K to 6.3 K (-1.40 %)
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	79.25	741	58,724	6,432	7.2 K to 6.4 K (-10.33 %)
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	78.55	4,598	361,173	7,173	11.8 K to 7.2 K (-39.06 %)
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	77.65	2,159	167,646	11,771	13.9 K to 11.8 K (-15.50 %)
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	76.43	1,412	107,919	13,930	15.3 K to 13.9 K (-9.20 %)
Nov 18 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	15,342	6.3 K to 15.3 K (+141.91 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	9,000	62,010	121,000
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	64.19	465	29,848	6,342	6.8 K to 6.3 K (-6.83 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	63.50	2,007	127,445	6,807	8.8 K to 6.8 K (-22.77 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	62.54	4,702	294,063	8,814	13.5 K to 8.8 K (-34.79 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	61.61	1,375	84,714	13,516	14.9 K to 13.5 K (-9.23 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	60.42	451	27,249	14,891	15.3 K to 14.9 K (-2.94 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	15,342	6.3 K to 15.3 K (+141.91 %)
Sep 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Option Exercise	M	6.89	9,000	62,010	130,000
Sep 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	64.69	4,440	287,224	6,342	10.8 K to 6.3 K (-41.18 %)
Sep 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	63.99	4,560	291,794	10,782	15.3 K to 10.8 K (-29.72 %)
Sep 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Buy	M	6.89	9,000	62,010	15,342	6.3 K to 15.3 K (+141.91 %)
Aug 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Option Exercise	M	6.89	9,000	62,010	139,000
Aug 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	61.83	671	41,488	5,218	5.9 K to 5.2 K (-11.39 %)
Aug 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	61.16	4,918	300,785	5,889	10.8 K to 5.9 K (-45.51 %)
Aug 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	60.26	3,411	205,547	10,807	14.2 K to 10.8 K (-23.99 %)
Aug 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Buy	M	6.89	9,000	62,010	14,218	5.2 K to 14.2 K (+172.48 %)
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Option Exercise	M	6.89	9,000	62,010	148,000
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	73.42	100	7,342	5,218	5.3 K to 5.2 K (-1.88 %)
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	72.65	3,951	287,040	5,318	9.3 K to 5.3 K (-42.63 %)
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	71.55	3,519	251,784	9,269	12.8 K to 9.3 K (-27.52 %)
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	70.92	1,024	72,622	12,788	13.8 K to 12.8 K (-7.41 %)
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	70.12	406	28,469	13,812	14.2 K to 13.8 K (-2.86 %)
Jul 20 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Buy	M	6.89	9,000	62,010	14,218	5.2 K to 14.2 K (+172.48 %)
Jun 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Option Exercise	M	6.89	9,000	62,010	157,000
Jun 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	58.04	3,095	179,634	5,218	8.3 K to 5.2 K (-37.23 %)
Jun 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	56.88	3,295	187,420	8,313	11.6 K to 8.3 K (-28.39 %)
Jun 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	55.93	2,610	145,977	11,608	14.2 K to 11.6 K (-18.36 %)
Jun 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Buy	M	6.89	9,000	62,010	14,218	5.2 K to 14.2 K (+172.48 %)
Jun 17 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Buy	P	17.00	4,000	68,000	5,218	1.2 K to 5.2 K (+328.41 %)
May 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Option Exercise	M	6.89	9,000	62,010	166,000
May 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	52.21	128	6,683	1,218	1.3 K to 1.2 K (-9.51 %)
May 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	51.57	1,528	78,799	1,346	2.9 K to 1.3 K (-53.17 %)
May 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	50.49	2,638	133,193	2,874	5.5 K to 2.9 K (-47.86 %)
May 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Sell	S	49.44	4,706	232,665	5,512	10.2 K to 5.5 K (-46.06 %)
May 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	VP Clinical Develop ...	Buy	M	6.89	9,000	62,010	10,218	1.2 K to 10.2 K (+738.92 %)

Page: 1